These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 21605196

  • 1. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species.
    Galgóczy L, Bácsi A, Homa M, Virágh M, Papp T, Vágvölgyi C.
    Mycoses; 2011 Nov; 54(6):e737-43. PubMed ID: 21605196
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of phenothiazines and their combinations with amphotericin B against Zygomycetes causing rhinocerebral zygomycosis.
    Galgóczy L, Papp T, Kovács L, Ordögh L, Vágvölgyi C.
    Med Mycol; 2009 May; 47(3):331-5. PubMed ID: 18798117
    [Abstract] [Full Text] [Related]

  • 3. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS, Chang SC, Hsueh PR, Wang JL, Sun HY, Chen YC.
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [Abstract] [Full Text] [Related]

  • 4. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
    Rukayadi Y, Lee K, Lee MS, Yong D, Hwang JK.
    FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
    [Abstract] [Full Text] [Related]

  • 5. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V, Barnes AJ.
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [Abstract] [Full Text] [Related]

  • 6. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [Abstract] [Full Text] [Related]

  • 7. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y, Akşit F, Kiraz N, Kiremitçi A.
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [Abstract] [Full Text] [Related]

  • 8. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 Jan; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 9. [Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media].
    Alp S, Sancak B, Arikan S.
    Mikrobiyol Bul; 2008 Apr; 42(2):293-300. PubMed ID: 18697427
    [Abstract] [Full Text] [Related]

  • 10. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
    Guinet R.
    Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 20. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT, Cañadas J, García-Martos P, Marín P, García-Tapia A, Rodríguez J.
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.